West Vancouver, British Columbia – June 30, 2016 – Canadian International Pharma Corp. (the “Company”) announces the resignation of Bruce Morley as a director of the Company, effective June 1, 2016. Mr. Morley will still continue to provide the Company with legal services through his law corporation. However, at this time, the Company wishes to thank Mr. Morley for his dedication and service as a member of the Company’s Board of Directors over many years.
For further information, contact Mr. Clive Shallow, Shareholder Communications, at 604-922-2030, or visit the Company’s website at www.canpharmacorp.ca.
CANADIAN INTERNATIONAL PHARMA CORP.
“Douglas L. Mason”
Douglas L. Mason, CEO
Neither the TSX Venture Exchange nor its Regulation Services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.